ReleaseWire Connect

Mobile advertising networks, exchanges, programmatic trading systems and direct publisher sales combined form a global marketplace worth $7.4 billion in unduplicated 2013 media billings. This sector analytics report presents a detailed accounting of global sales by territory, including the U.S., Europe, AsiaPac, Africa and Latin America, calculated against inventory requests, formats, pricing by region, fill rates, CTRs and eCPMs.

China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion. On the Chinese healthcare market, imported drugs made by overseas and multinational pharmaceutical manufacturers account for about one fourth. It is estimated that total value of drugs on Chinese healthcare market will be likely to be more than 1450 billion RMB by 2015, and will surpass Japan to become the second largest drug market following the United States. The Chinese healthcare market will attract more and more overseas pharmaceutical manufacturers and producers to penetrate such market.

Streaming music radio, curated station and track play listening hours are spinning ahead at a 2013 growth rate of 47.5%, backed by monetization initiatives channeling $1.22 billion into the digital music ecosystem.

China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US$246 billion). China is expected to become the second largest drug market in the world by 2015 with a growth rate over 25 percent per annum in next three years. As China joins the World Trade Organization (WTO) and integrates more completely into the global economy, it will further open the door to a lucrative drug market for overseas pharmaceutical companies, which attracts more and more overseas pharmaceutical manufacturers and producers to enter such drug market and seize a larger part of such drug market. However, the Chinese social environment for the protection of intellectual property right is complex. The locally produced generics and copy products dominate the Chinese drug market. It is estimated that about 97 percent of the drugs produced by local companies are generics or counterfeits.

This market research report offers a perspective on the actual market situation, trends and future outlook for agricultural and forestry machinery in China. The study provides essential market information for decision-makers including:

Report by AMR observed that Global In vitro fertilization market will reach a figure of $21.6 billion by 2020 with a CAGR of 11.6% between 2013 and 2020. In 2012, it stood at $9.3 billion.

The study observed that the global Mhealth market was valued at $6.7 billion in 2012 and is estimated to reach $8.3 billion by the end of 2013. With growing per capita healthcare expenditure both in developed and advanced developing countries, the mobile healthcare market is further projected to reach $58.8 billion by 2020, at a CAGR of 32.3% from 2013 to 2020.

A new report titled " Global Smart Homes, Buildings (Energy Efficient, Automated) Market (Applications, Technologies, Products and End-User) - Size, Share, Trends, Analysis, Research, Future Demand, Scope and Forecast, 2013 - 2020,” Big Market Research

A new report “Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 – 2020” by allied market research is published at big market research.com